Sylvia Cheung | Chief Financial Officer |
Joseph Darling | President and Chief Executive Officer |
Joe Munda | First Analysis |
Jim Sidoti | Sidoti & Company |
Lisa Springer | Singular Research |
Good evening, ladies and gentlemen, and welcome to the Anika Therapeutics Second Quarter 2019 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this call may be recorded.
I would now like to turn the call over to Sylvia Cheung, Chief Financial Officer.